Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2

OBJECTIVE: To evaluate the efficacy and safety of eptinezumab, a humanized anti–calcitonin gene-related peptide monoclonal antibody, in the preventive treatment of chronic migraine (CM). METHODS: The Prevention of Migraine via Intravenous ALD403 Safety and Efficacy–2 (PROMISE-2) study was a phase 3,...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neurology
Hoofdauteurs: Lipton, Richard B., Goadsby, Peter J., Smith, Jeff, Schaeffler, Barbara A., Biondi, David M., Hirman, Joe, Pederson, Susan, Allan, Brent, Cady, Roger
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Lippincott Williams & Wilkins 2020
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7274916/
https://ncbi.nlm.nih.gov/pubmed/32209650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000009169
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items